DAX 13.920 -1,8%  MDAX 28.894 -1,9%  Dow 31.672 -0,7%  Nasdaq 11.743 -2,4%  Gold 1.866 0,7%  TecDAX 3.060 -1,1%  EStoxx50 3.648 -1,6%  Nikkei 26.748 -0,9%  Dollar 1,0740 0,5%  Öl 113,3 -0,1% 

Aktionärsstruktur

Inhaber in %
Freefloat 73,50
UBS Asset Management Switzerland AG 3,09
Camber Capital Management LP 2,54
Johnson & Johnson 2,53
Pictet Asset Management SA 2,23
Andreas Plückthun 2,01
Patrik Forrer 1,99

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2017 2018 2019 2020 2021
Personal am Ende des Jahres 119 129 147 159 177
Umsatz pro Mitarbeiter in Mio. EUR 0,17 0,08 0,14 0,06 0,06

Bilanz (in Mio. EUR) - Aktiva

2017 2018 2019 2020 2021
Summe Umlaufvermögen 143 153 100 178 164
Summe Anlagevermögen 117 92 57 114 113
Summe Aktiva 144 155 105 188 173

Bilanz (in Mio. EUR) - Passiva

2017 2018 2019 2020 2021
Gesamtverschuldung/ -verbindlichkeiten 0 0 3 7 6
Summe Fremdkapital 28 63 51 80 65
Summe Eigenkapital 117 92 54 107 107
Summe Passiva 144 155 105 188 173

Adresse

Wagistrasse 14, 8952 Schlieren
Telefon +41 (44) 755-77-00
Fax +41 (44) 755-77-07
Internet http://www.molecularpartners.com

Management

Agnete Brunsvik Fredriksen
Independent Director
Andreas Emmenegger
Chief Financial Officer
Daniel Steiner
Senior Vice President-Research
Dominik Höchli
Independent Director
Julien Gander
General Counsel & Vice President-Legal
Michael J. Vasconcelles
Independent Non-Executive Director
Michael Tobias Stumpp
Chief Operating Officer
Nicolas Leupin
Chief Medical Officer
Patrick Amstutz
Chief Executive Officer & Director
Philippe Legenne
Vice President-Clinical Development
Renate Gloggner
Senior Vice President-Human Resources
Sandipkumar S. Kapadia
Independent Director
Seth D. Lewis
SVP-Investor Relations, Communications & Strategy
Steven H. Holtzman
Independent Non-Executive Director
Thomas Schneckenburger
Head-Media
Vito J. Palombella
Independent Non-Executive Director
William Matt Burns
Chairman